| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	FDA approves expanded Credelio Quattro and Credelio labels to include prevention of Lyme disease as a result of killing black-...
 
																	Elanco Animal Health Incorporated (NYSE:ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. F...
 
																	UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $19 to $25.
 
																	
 
																	
 
																	JP Morgan analyst Chris Schott upgrades Elanco Animal Health (NYSE:ELAN) from Neutral to Overweight and raises the price tar...
 
																	
 
																	Stifel analyst Jonathan Block maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $18 to ...